Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease

Recruiting now

Conditions studied: Malignant Neoplasms, Hereditary Neoplastic Syndromes, Kidney Cancer, Renal Cancer, Bladder Cancer

In brief

Selected individuals suspected of having or with prior biopsy proof of malignant disease will be seen in the Urologic Oncology Branch, NCI. Blood samples may be collected at the time of the initial visit and at periodic intervals during the course of the disease. These samples will be stored in the tissue bank of the Urologic Oncology Branch. Aliquots of malignant and normal tissue will be collected at the time of surgery and stored in the tissue bank, Urologic Oncology Branch, NCI. These materials will be used in the research efforts of the Urologic Oncology Branch, NCI.

Key facts

Study ID

NCT00026884

Run by

National Cancer Institute (NCI)

People needed

5950

Starts

1998-03-12

Last updated by the study team

2026-07-02

Who can join

Age: 2 and older. Sex: any. Healthy volunteers: accepted.

You may not qualify if…

• Individuals whose co-morbidities preclude surgical intervention.

Where it is running

• National Institutes of Health Clinical Center — Bethesda, Maryland, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.